Evaluation of a new ELISA assay for monoclonal free‐light chain detection in patients with cardiac amyloidosis-Reference-Cited by-同舟云学术

Evaluation of a new ELISA assay for monoclonal free‐light chain detection in patients with cardiac amyloidosis

Published:2022-06-24 Issue:3 Volume:3 Page:828-837
ISSN:2688-6146
Container-title:eJHaem
language:en
Short-container-title:eJHaem

Author:

Abroud Hajer¹,Beldi‐Ferchiou Asma¹²,Audard Vincent³⁴^ORCID,Lemonnier François³⁵,Le Bras Fabien³⁵,Belhadj Karim³⁵^ORCID,Moktefi Anissa³⁶^ORCID,Poullot Elsa³⁶,El Karoui Khalil³⁴,Dupuis Jehan³⁵,Maarek Alizée³⁵,Roulin Louise³⁵,Delfau‐Larue Marie‐Hélène¹²,Oghina Silvia³⁷,Kharoubi Mounira³⁷,Bézard Mélanie³⁷,Zaroui Amira³⁷,Damy Thibaud³⁷⁸,Molinier‐Frenkel Valérie¹²³^ORCID

Affiliation:

1. Département d'Hématologie‐Immunologie AP‐HP, Hopital Henri Mondor Creteil France

2. INSERM IMRB Univ Paris Est Creteil Creteil France

3. French Referral Centre for Cardiac Amyloidosis Cardiogen Network GRC Amyloid Research Institute Henri Mondor Hospital Creteil France

4. Service de Néphrologie et Transplantation AP‐HP, Hopital Henri Mondor Creteil France

5. Unité Hémopathies Lymphoïdes AP‐HP, Hopital Henri Mondor Creteil France

6. Département de Pathologie AP‐HP, Hopital Henri Mondor Creteil France

7. Département de Cardiologie AP‐HP, Hopital Henri Mondor Creteil France

8. INSERM, IMRB, CEPiaA Univ Paris Est Creteil Creteil France

Publisher

Wiley

Subject

General Earth and Planetary Sciences

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jha2.516

Reference41 articles.

1. Systemic immunoglobulin light chain amyloidosis

2. Amyloidosis

3. Epidemiology of AL amyloidosis: a real-world study using US claims data

4. What is new in diagnosis and management of light chain amyloidosis?

5. Systemic light chain amyloidosis: an update for treating physicians

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Performance Characteristics and Limitations of the Available Assays for the Detection and Quantitation of Monoclonal Free Light Chains and New Emerging Methodologies;Antibodies;2024-03-11

2. Bad players in AL amyloidosis in the current era of treatment;Expert Review of Hematology;2023-01-02